Micro Emerging Active

Morgan Stanley boosts GILD outlook on updated biopharma models

New narrative with limited coverage — still forming.

Score
0.5
Velocity
▲ 1.0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Apr 17, 2026
Jim Cramer on Gilead Sciences: “I’d Hold On to It” Bullish
Apr 15, 2026
Morgan Stanley Boosts Gilead (GILD) Outlook on Updated Biopharma Models Neutral

Related Articles

Jim Cramer on Gilead Sciences: “I’d Hold On to It”

Yahoo Finance · Apr 17, 2026
Mixed

Timeline

Last UpdatedApr 15, 2026